Maynard Um
-
-
-
-
-
-
-
'Arrowhead Pharma (ARWR) Raises $930 Million to Launch Redemplo'; PT Raised at Piper Sandler
-
-
-
-
-
-
-
Arrowhead Pharmaceuticals reports interim obesity drug trial results
-
-
-
-
-
-
-
Piper Sandler Names Arrowhead Pharma (ARWR) 'A Top Pick for 2026', Lifts Stock PT
-
-
-
-
-
-
-
Arrowhead Pharma (ARWR) PT Raised at RBC Capital Following Redemplo Approval
-
-
-
-
-
-
-
Arrowhead Pharma (ARWR) PT Raised to $45 at Morgan Stanley
-
-
-
-
-
-
-
Arrowhead receives $100 million milestone from Sarepta in mixed payment
-
-
-
-
-
-
-
Arrowhead Pharma (ARWR) PT Lowered to $40 at RBC Capital
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

